Device Vascular/Oncology

Rival

Payments companies reported to CMS as associated with Rival. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$470associated payments (2023-2025)
2clinicians with associated payments
1company reporting

By year

2023 $210
2025 $260

Payments reported as associated with Rival, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $470

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Rival

These are the largest totals companies reported as associated with Rival. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Gerald Koenig Detroit, MI Cardiovascular Disease $260.16
Louis Lopez Fort Wayne, IN Cardiovascular Disease $209.90

Prescribed Rival?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.